FDA Launches NAIN Program for Neuroscience
The FDA has announced the creation of the Neuroscience Advancement and Innovation Nexus (NAIN) to accelerate medical innovation and deliver breakthrough treatments.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed